N-Hydroxysuccinimide | CAS:6066-82-6

We serve N-Hydroxysuccinimide CAS:6066-82-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-Hydroxysuccinimide

Chemical Name:N-Hydroxysuccinimide
CAS.NO:6066-82-6
Synonyms:1-hydroxypyrrolidine-2,5-dione; 2,5-Pyrrolidinedione, 1-hydroxy-;NHS
Molecular Formula:C4H5NO3
Molecular Weight:115.08700
 
Physical and Chemical Properties:
Density:1.649;
Melting point:95-98oC;
Boiling point:262.4oC;
Flash point:112.5oC;
Index of Refraction:1.599;
 
HS Code: 2925190090
 
Specification:
Appearance:White crystal powder
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 



Contact us for information like N-Hydroxysuccinimide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,NHS physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,5-Pyrrolidinedione, 1-hydroxy- Use and application,2,5-Pyrrolidinedione, 1-hydroxy- technical grade,usp/ep/jp grade.


Related News: The UK Foreign Office advised Britons against all but essential travel to mainland China, and airlines around the world suspended flights or offered full refunds or destination and date changes.N-phenyl-[1,1',4',1''-terphenyl]-4-amine manufacturer After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate supplier China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate vendor China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15.